OptiMed家庭输液疗法使患者的治疗步入正轨,同时降低了COVID-19的风险。

全美家庭输液协会发布建议,促进患者安全并控制成本

KALAMAZOO, Mich., April 6, 2020 (Newswire.com) - As COVID-19 cases spread rapidly across the U.S., there is a new call by the National Home Infusion Association (NHIA) to treat patients needing specialty infusions in their homes offered by OptiMed, a home infusion pharmacy with national capabilities.

NHIA是家庭输液治疗的主要声音,它于3月30日发表声明,鼓励利用家庭输液来帮助患者坚持治疗,同时降低接触COVID-19的风险。

"Home infusion pharmacies have safely and effectively treated patients in the home for decades," the statement reads. "While the demand for these services by commercial payers has been largely focused on the cost-effectiveness of home infusion, this site of care has the additional benefits of freeing up hospital resources to treat those most in need and limiting exposure to pathogens. This makes home infusion a powerful tool in the fight against COVID-19."

Andy Reeves, CEO of Michigan-based OptiMed, said there’s already been an increase in transitioning patients to home infusion therapy in the past two weeks because of COVID-19. He said home infusion is not only safer and more convenient but typically is less costly.

家庭输液是指护士在患者舒适的家中为其提供输液服务。治疗提供者通过高技能的专业团队,包括输液药剂师、输液护士、护理经理和处方提供者来协调患者的护理,从而确保患者得到最佳治疗。

“Our expertise has always been delivering patient-centered care that is safe, timely, clinically sound, and cost-effective,” said Reeves. “During COVID-19, we are committed to providing an impactful solution for patients, payers, and health systems through our ability to expeditiously transition patients on specialty infusions to receive care safely in their homes.”

About OptiMed:  OptiMed Health Partners, headquartered in Kalamazoo, Michigan, is an independently owned and operated national healthcare organization. With over 25 years of experience, OptiMed leverages personalized attention to detail to deliver customized solutions that optimize patient outcomes while partnering with other healthcare organizations to usher in a new standard of excellence. To learn more about OptiMed’s innovative and personalized care, visit OptiMedHP.com.

If you or someone you know is receiving infused or injected therapies, please contact OptiMed at 877-232-2857 to discuss treatment options and the benefits of in-home services.

上一篇
上一篇

Advanced Medical Strategies宣布与OptiMed Health Partners合作

下一个
下一个

OptiMed被评为"全美最佳和最有前途的公司®"和"西密歇根州最佳和最有前途的公司®"之一。